explore -WSS

explore

author：explore 2025-10-04 03:59:48 - browse：6972

Dallas Mavericks owner Mark Cuban reacts during a timeout in the game against the Golden State Warriors at American Airlines Center on March 22, 2023 in Dallas, Texas. – opinion coverage from STAT — Tim Heitman/Getty Images

Mark Cuban, the Dallas Mavericks owner and “Shark Tank” star, has been making headlines recently with his direct-to-consumer venture, Cost Plus Drugs. The company sells generic prescription drugs and boasts more than 2 million members. As a family medicine specialist who has firsthand experience with American households’ dissatisfaction with the state of the nation’s prescription drug marketplace, I believe the enthusiasm for Cost Plus Drugs reveals an appetite for alternatives to the status quo in the pharmaceutical industry.

Cuban claims the reason behind the success of Cost Plus Drugs is the company’s decision to bypass pharmaceutical benefit managers — the negotiating agents insurance companies hire to negotiate big pharma’s prices down. But that might not be the case. Instead, its success appears to lie in its choice to collaborate with affordable generic drug manufacturers rather than the major pharmaceutical companies.

Last year, the Department of Health and Human Services found that between July 2021 and July 2022, major pharma companies raised the list price on more than 1,200 drugs by an average of 31 percent. That’s 23 percent more than the country’s overall inflation rate during the same period. Meanwhile, generic drug companies saved the U.S. roughly $2.6 trillion from 2012 to 2021, according to the Association for Accessible Medicines, a trade group representing generic drug manufacturers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： What AAP's gender

hotspot

WSS

FDA panel gives mixed vote on blood pressure devices

Winners, losers from Medicare’s list of drugs subject to price talks

Study finds new variant for Parkinson’s in African populations

Apellis safety probe of eye disease drug centers on injection needle

How to make AI work for medicine

FDA panel gives mixed vote on blood pressure devices

hotspot

explore

entertainment

Anesthesiologist group: stop taking Ozempic before surgery

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

George Santos makes 1st court appearance after pleading not guilty to 13 counts

CDC advisory panel says seniors 'may' get RSV vaccine

New air purifier tech could be key to improving indoor air quality

Departing Stanford president retracts two papers

ChatGPT in medicine: STAT answers readers' burning questions

Feds fine Medicare Advantage plans for overcharging members

Supreme Court strikes down use of affirmative action

AstraZeneca challenges Medicare drug negotiation program

focus

AstraZeneca bets AAV gene therapy will still deliver the goods

What do new weight loss drugs mean for bariatric surgery?

Diversity in medical illustrations gets boost from Chidiebere Ibe

As pharma fights Medicare drug negotiation, hospitals, docs silent

FDA panel gives mixed vote on blood pressure devices

2024 GOP presidential candidates spar over abortion in debate

hotspot

focus

entertainment

hotspot